- Sun Pharmaceutical Industries Limited has received approval from the U.S. Food and Drug Administration (FDA) for LEQSELVI™ (deuruxolitinib), an oral JAK inhibitor for treating severe alopecia…
Join the vibrant privacy-ensured Dzambhala community on
Want to give feedback on this story? Write to us at [email protected]